Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-20

Clinical Trial Update: Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating circulating tumor DNA methylation-guided postoperative adjuvant chemotherapy for high-risk stage II and stage III colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer | Phase 3 | Status: RECRUITING